跳至主要内容
临床试验/DRKS00006785
DRKS00006785已完成未知

Deep Brain Stimulation (DBS) of the Globus pallidus (GP) in Huntington’s disease (HD): A prospective, randomised, controlled, international, multi-centre study - HD-DBS

niversität Düsseldorf0 个研究点目标入组 48 人开始时间: 2014年9月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Clinically symptomatic and genetically confirmed HD (number of CAG repeats = 36)
  • Age =18 years
  • Moderate stage of the disease (UHDRS motor score = 30)
  • Chorea despite best medical treatment (UHDRS chorea subscore = 10)
  • Mattis Dementia Rating Scale = 120 (or > 80% of items testable independently from motor impairment)
  • Patient has stable medication prior six weeks before inclusion
  • Signed informed consent

排除标准

  • Juvenile HD (Westphal variant) or predominant bradykinesia
  • Postural instability with UHDRS retropulsion score > 2
  • Severe comorbidity compromising operability and/or life expectancy and/or quality of life during the trial duration (e.g. cancer with life expectancy < 6 months, NYHA 3 and 4 rising the anaesthetic risk according to the anaesthesiologist)
  • Acute suicidality
  • Acute psychosis (symptoms within previous 6 months)
  • Participation in any interventional clinical trial within 2 months before baseline
  • Cortical atrophy grade 3
  • Patients with risk of coagulopathies and/or increased risk of haemorrhage
  • Patients with an implanted pacemaker or defibrillator

研究者

发起方
niversität Düsseldorf

相似试验